Yi Su-Qin, An Jia-Xing, Liao Cheng-Cheng, Lei Sha, Jin Hai, Tuo Bi-Guang
Department of Gastroenterology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Special Key Laboratory of Oral Disease Research, Higher Education Institution in Guizhou Province, School of Stomatology, Zunyi Medical University, Zunyi, Guizhou, China.
Neoplasma. 2021 Sep;68(5):907-916. doi: 10.4149/neo_2021_210219N226. Epub 2021 Sep 17.
The corticotropin-releasing hormone (CRH) family is widely distributed among the central nervous system and peripheral tissues, such as the digestive, cardiovascular, immune, reproductive, endocrine systems. The CRH family members are widely involved in the regulation of human cell biological processes, immune response, and regulation of inflammatory processes that can affect the occurrence and development of tumors. At present, CRH family members and their receptors can be detected in many tumor tissues, and some people think that members of the CRH family may be potential tumor treatment targets as they can affect cellular processes, such as proliferation, migration, invasion, and apoptosis. However currently, there is no systematic introduction to the relationship between the CRH family and various tumors. This review introduces the molecular regulation of the CRH family in tumor formation and seeks further targeted therapy.
促肾上腺皮质激素释放激素(CRH)家族广泛分布于中枢神经系统和外周组织,如消化、心血管、免疫、生殖、内分泌系统。CRH家族成员广泛参与人类细胞生物学过程、免疫反应以及炎症过程的调节,而这些过程会影响肿瘤的发生和发展。目前,在许多肿瘤组织中都能检测到CRH家族成员及其受体,一些人认为CRH家族成员可能是潜在的肿瘤治疗靶点,因为它们可以影响细胞增殖、迁移、侵袭和凋亡等细胞过程。然而,目前尚无关于CRH家族与各种肿瘤之间关系的系统介绍。本文综述介绍了CRH家族在肿瘤形成中的分子调控,并寻求进一步的靶向治疗。